9999999997-14-014516.txt : 20141022 9999999997-14-014516.hdr.sgml : 20141022 20141022141805 ACCESSION NUMBER: 9999999997-14-014516 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20141022 DATE AS OF CHANGE: 20141022 20141022 20141022 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PROTEON THERAPEUTICS INC CENTRAL INDEX KEY: 0001359931 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1933 Act SEC FILE NUMBER: 333-198777 FILM NUMBER: 141167496 BUSINESS ADDRESS: STREET 1: 200 WEST STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 781-890-0102 MAIL ADDRESS: STREET 1: 200 WEST STREET CITY: WALTHAM STATE: MA ZIP: 02451 CT ORDER 1 filename1.pdf begin 644 filename1.pdf M)5!$1BTQ+C4-"B6UM;6U#0HQ(#`@;V)J#0H\/"]4>7!E+T-A=&%L;V7!E+U!A9V5S+T-O=6YT(#$O2VED'0O26UA9V5"+TEM86=E0R]);6%G94E=(#X^+TUE9&EA0F]X6R`P(#`@-C$R M(#2]#4R]$979I8V521T(^/B]486)S+U,O4W1R=6-T4&%R96YT M)R566%OVS@2_1X@_X'`?9&`A!5) MD9(6BP52)^FZN"1%X@(';`\')Y9K`;;DM>7=]M_?S%"R+5M4N`WJV,K3S'#X M^&9&9A^^L%]__?`P&M^RZ+??V,?;$?LXN;SX<"^8D&PRO[P0+((?P;*(1S)F M293RS+#)ZO(B8M_QY=/EQ1\!"__+)I\O+^[@9C2POTOR+.K3 M.[SVXEB4THIGNFMJ,![5$X](#$]29DS"=6OD91_)Z"M$]CR>C/$#7:&_L1N, M^);=_2<4(AC]3A\_A:F%L-'30WBM@P=W.M1!]8KNH:-$1$0ZB%L=A8`CLW0$=>ZZW4P]*0O='M&C)`G+,?H)[_O M^<4\J#:"Z[0:]G0/ZP;;2KEB%X9.Q+';P=A3]][I+/5D8];'1I5PHYE.XP.+ MON!A00I6N%EU'B9!5=(::7F+8Y9.U^VG';ZIBS<@\M9)V12WK./LBHUIR\G! MF^O&!*3CY$;NQ,9GV&$)C7KRHB+#(["21)X'0_0IL90QUPG3.CEP]!ZS6RS; MM+''BC/E9(I,-=>J:^':B'3A)CGBNA\.WMK8JR(%/!K?VS_U_?/ M%87)>)1T[Q^.0G6:#.EH,K3,>**]#/95I-:*T"A*P]LE0&XCV<5^02YO*A`* MJ&$EFRSPS68*LK%&`2%QJ`M[OF.G.$@@F,RZEJ^H7(RQ5I3X#N_G;+M[7:$0 M%35)3CYCT]`$);S&P7J]W'O"S^@7[H:P=N6,1,NULAA.?';B_]FIWYI'JHO= MN;!2G&&7.;IC&\@3QO3GSN8)ZN06`XZ#\GL(FNCL$IL-BR07K4E<<%7.BQDF MO[3IQ@0L&65I@RI."5FURE/6D%TX8_-J0^)>E/@N#E;3NH!\D86:Y3_P,*+U MY6X&J9[CWE8K5B]R=@=7?V#HB^+5PK<,W-05F[)[*/9HV`0KYFH,8Y#J).NN MPZ4I<9(BQSM8\4Z"XC3%4F#!D`'@#.6UV-:89**HS12L%Z])FZ)\U>1G7BSA MKC28,0"X>*L,-UG7UTN;XS78>K6UTJ79"<]4]VZG)UC6*5:8IDF$77!61$6U MS.GC7"4&6D7<,^UGI:]7;*V8J%^Q>K2F@_W8T'B;0X-HMP563NQ>$]OR]H]E M33S>`L>A)7M%V,]0N@^5-(JR>^SM3-F0#+2=_U3=E#%8L#K66W63'76K%],: M7LCBMCF4JCV4[_`]-@>-^7-'QY_LS`MJM4J1UG" M6(KIDI%SBG->E%.4EO8O`SV%4-U0"M*9<@ZFCA>#BHR^2$MLR3=!LXG75AEG MH#35_+UE*W70A$.QP,29UM<-AEU?,:%N72UMG_RZ:TI6? MU0;'BC4L-3;=%;^7G4@?-.CO8DG--,,TO>;[HKK,L2MH=`)*DHVX/;+=3+(] M-6';7?J0:-*'8]]DR7)@E;-U3G)15#.G$&?8XG1,.,]1+,^PVW7^!KI3P'&> M_>+L=%-L8YP^SF6Z;RYN$JTRX=M8#DRH*DF\&TL_K)'^6!B/3[%W/U#\B)@& M6AP!9=6UZ3`P*.7G2<*L"&76"]N,EQULO=A4N^\X]2S848BQB'%3^LCORQJ>'"#3UG5M]CBY99)CXH__`CSKXA MO[4"T<,F^_'S&(NBWZI&#H6!II*5K=S;IC(XIQW(;M8U=W7FN;SRL0N@COYT MI2V%?CWMVG5)ET@U-Z:+'=[4@:??2DJ>^%GI&_5;*_@@WL]*WT/KQHK,J"?R ML3(PGTM\?NY)4S^LE5$_K)51+ZQ4,8J;']:*IA>V$&!XEOAE MC9^5@>%9XKCN)7YSX61GH[21^A>%G9:".(V7\LJL&ZKC`1_Y>1@;J MAL`G_EY&!LJ&P.?,7D8&JH;`Q\1>1@:*AI`9]VJ05!]MF^,IA.Y-;,_I]($V MA],+"E.0+]0JM0^T$6HOJ-5I+RC)M`]20V_B1M+6_!\$D*P1#0IE;F1S=')E M86T-"F5N9&]B:@T*-2`P(&]B:@T*/#PO5'EP92]&;VYT+U-U8G1Y<&4O5')U M951Y<&4O3F%M92]&,2]"87-E1F]N="]4:6UE)SEEL]*Y$`0QN^"[U!OD-2?[B0@PK(JNX@BCK`' M\1#'WG%P)I&8`7W[K4Z-.(<];.JZ,*32G?I^J>I\]#0*E(`5!`2L`4L";``# M`Y7Z$R`$"@&(@,L(Q,"A`A*0LM8'(*$!BJK6;(5$`JHAHNH:B#&J""KE,D)5 ME<`$=28QU)4`"S2JY0!-I2E1WZ[I7&FL-4FK04UA+0?KJ"\$))T4+92:$D0K M9;T(:VRT(`$4T;R@L=$\Y86@>4[$8A]UR/-^D;7%Y#^4# M%#BP`#H\@`X3H,,%Z+`!.GQ`#A^09Q]P^(`ZZ6D^K>29::LWS,'3 MZ_0^7J8/P#WZ0EE=/Z;B.E_.NZ>OP9VF/O;OQ2(MQ^)':I_28/=9\WG_L]NL MN[1X;G.%>>);IX1V7/?=?CR,Z]^MWDRC7_WP\MCW+\59O]QMM:9IYNTYI=$< M<-4NA_Y@_/U9KP?CLW6[Z5<'$XO-^BD=Y-I[-&TUM-OB8KW:#6G?Z_5N^W:? MC[KA:W7_F4@-30O5UL@,2`T(#)=("]2;V]T M(#$@,"!2+TEN9F\@.2`P(%(O241;/#4U,S%!0S5"0D$Q.#9%-$%"-D,S,T4S M131$-S$V.3,Q/CPU-3,Q04,U0D)!,3@V131!0C9#,S-%,T4T1#:T3M((J&J MRH3N1;Y')E9@T*-3(P,@T*)25%3T8-"GAR968-"C`@,`T*=')A:6QE<@T*/#PO M4VEZ92`U-2]2;V]T(#$@,"!2+TEN9F\@.2`P(%(O241;/#4U,S%!0S5"0D$Q M.#9%-$%"-D,S,T4S131$-S$V.3,Q/CPU-3,Q04,U0D)!,3@V131!0C9#,S-% M,T4T1#')E9@T*-C0U-PT*)25%3T8_ ` end